Mechanisms of action of androgens and antiandrogens: Effects of antiandrogens on translocation of cytoplasmic androgen receptor and nuclear abundance of dihydrotestosterone

No abstract is available for this paper.

• Publication year

  1982

• Venue

  The Prostate

• Publication date

  Unknown publication date

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/pros.2990030609PMID 7155992
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endogenous androgen levels in epithelium and stroma of human benign prostatic hyperplasia and normal prostate.

  1982cited by this paper
• Androgen-dependent regulation of androgen nuclear receptor in the rat ventral prostate.

  1982cited by this paper
• The effects of flutamide on total DHT and nuclear DHT levels in the human prostate

  1981cited by this paper
• Partial purification of nuclear androgen receptor by micrococcal nuclease digestion of chromatin and hydrophobic interaction chromatography.

  1981cited by this paper
• Medical castration of males with megestrol acetate and small doses of diethylstilbestrol.

  1981cited by this paper
• Distribution and concentrations of androgens in epithelial and stromal compartments of the human benign hypertrophic prostate.

  1981cited by this paper
• Prostatic tissue distribution of 17β-hydroxy-5α-androstan-3-one and of androgen receptors in benign hyperplasia

  1980cited by this paper
• Prostatic tissue distribution of 17 beta-hydroxy-5 alpha-androstan-3-one and of androgen receptors in benign hyperplasia.

  1980cited by this paper
• Assay of nuclear androgen receptor in human prostate.

  1979cited by this paper
• Mechanisms of replenishment of nuclear androgen receptor in rat ventral prostate.

  1978cited by this paper
• The nuclear uptake of androgen by human benign prostate in vitro: action of antiandrogens.

  1978cited by this paper
• The Mechanism of Action of Androgens

  1977cited by this paper
• The effect of antiandrogens and stilboestrol on the cytosol receptor in rat prostate.

  1977cited by this paper
• The relationship between adrogen receptors and the hormonally controlled responses of rat ventral prostate.

  1976cited by this paper
• Studies on the regulation of the concentration of androgens and androgen receptors in nuclei of prostatic cells.

  1975cited by this paper
• Hormonal effects on cell proliferation in rat prostate.

  1975cited by this paper
• A radioimmunoassay for plasma testosterone.

  1970cited by this paper
• A study of the conditions and mechanism of the diphenylamine reaction for the colorimetric estimation of deoxyribonucleic acid.

  1956cited by this paper

• Enzalutamide and blocking androgen receptor in advanced prostate cancer: lessons learnt from the history of drug development of antiandrogens

  2018influential citation
• Immunohistochemical analysis in ethinylestradiol-treated breast cancers after prior long-term estrogen-deprivation therapy

  2015cites this paper
• Side gland of Suncus murinus as a new model of sebaceous gland: 5α-reductase, androgen receptor, and nuclear androgen content in male and female animals

  2004cites this paper
• P‐glycoprotein increases the efflux of the androgen dihydrotestosterone and reduces androgen responsive gene activity in prostate tumor cells

  2004cites this paper
• Morphofunctional study of the effects of fetal exposure to cyproterone acetate on the hypothalamo-pituitary-gonadal axis of adult rats

  2004cites this paper
• Clinical Pharmacokinetics of the Antiandrogens and Their Efficacy in Prostate Cancer

  1998cites this paper
• Treatment of hyperandrogenism in women

  1996cites this paper
• A combined regimen of cyproterone acetate and testosterone enanthate as a potentially highly effective male contraceptive.

  1996cites this paper
• Relative potency of antiandrogens with reference to intracellular testosterone in the rat prostate

  1996cites this paper
• Update of hormonal treatment in cancer of the prostate.

  1993cites this paper
• Androgens and androgen-receptors in prostate tissue from patients with benign prostatic hyperplasia: effects of cyproterone acetate.

  1992cites this paper
• Effects of in vivo dihydrotestosterone treatment on changes in nocturnal surge of prolactin, luteal ultrastructure and P-450scc mRNA and protein content in pregnant rats.

  1991cites this paper
• Effects of steroidal and non-steroidal antiandrogens on the androgen binding properties of the rat ventral prostate androgen receptor.

  1991cites this paper
• Use of cyproterone acetate in prostate cancer.

  1991cites this paper
• [A study of the androgenic activity of anti-androgen].

  1990cites this paper
• Studies on the mechanism of action of Win 49596: a steroidal androgen receptor antagonist.

  1989cites this paper
• Transplantable human prostatic carcinoma (PC‐82) in athymic nude mice. II. Tumor growth and androgen receptors

  1988cites this paper
• The combination of cyproterone acetate and low dose diethylstilbestrol in the treatment of advanced prostatic carcinoma.

  1988cites this paper
• Treatment with antiandrogens induces an androgen‐repressed gene in the rat ventral prostate

  1988cites this paper
• Antiandrogens in Combination with LH‐RH Agonists in Prostate Cancer

  1988cites this paper
• Relative effectiveness of alternative androgen withdrawal therapies in initiating regression of rat prostate.

  1988cites this paper
• Relationship of Androgen Receptors to the Growth and Regression of the Prostate

  1988cites this paper
• Transplantable human prostatic carcinoma (PC‐82) in athymic nude mice: I. Hormone dependence and the concentration of androgens in plasma and tumor tissue

  1988cites this paper
• The cellular mechanism of the antiandrogenic action of nomegestrol acetate, a new 19-nor progestagen, on the rat prostate.

  1987cites this paper
• Chemical demonstration of nuclear androgen receptor following affinity chromatography with immobilized ligands

  1987cites this paper
• Effectiveness of antiandrogens in the rat.

  1986cites this paper
• Hormone agonists and antagonists in the treatment of hormone sensitive breast and prostate cancer.

  1986cites this paper
• Variability of androgen-related phenotypes in the Shionogi mammary carcinoma during growth, involution, recurrence, and progression to hormonal independence.

  1985cites this paper
• Effect of a nonsteroidal antiandrogen, flutamide, on androgen receptor dynamics and ornithine decarboxylase gene expression in mouse kidney.

  1985cites this paper
• Interaction of cyproterone acetate with rat prostatic androgen receptors.

  1985cites this paper
• Interactions of an anti-androgen (cyproterone acetate) with the androgen receptor system and its biological action in the rat ventral prostate.

  1985cites this paper
• Androgen antagonists in androgen target tissues.

  1984cites this paper
• Androgenic control of acetate incorporation into phospholipids and triacylglycerols in rat ventral prostate.

  1984cites this paper
• Effect of flutamide or cyproterone acetate on pituitary and testicular hormones in normal men.

  1984cites this paper
• Androgen receptor assays in advanced prostatic cancer.

  1984cites this paper
• Anti-androgens do not alter androgen-dependent characteristics of acid phosphatase in the rat ventral prostate.

  1984cites this paper
• Androgen and antiandrogen receptor binding.

  1984cites this paper
• Progestins can mimic, inhibit and potentiate the actions of androgens.

  1983cites this paper
• Cyproterone acetate prevents translocation of the androgen receptor in the rat prostate.

  1983cites this paper